SGLT inhibition in patients with type 1 diabetes

被引:1
作者
Dehn, Clayton A. [1 ]
机构
[1] Celerion, Metab Dis, Tempe, AZ 85283 USA
关键词
D O I
10.1016/S2213-8587(14)70112-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:539 / 539
页数:1
相关论文
共 4 条
[1]   Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients [J].
Ferrannini, Ele ;
Muscelli, Elza ;
Frascerra, Silvia ;
Baldi, Simona ;
Mari, Andrea ;
Heise, Tim ;
Broedl, Uli C. ;
Woerle, Hans-Juergen .
JOURNAL OF CLINICAL INVESTIGATION, 2014, 124 (02) :499-508
[2]  
Henry RR, 2013, 73 AM DIAB ASS SCI S
[3]   Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production [J].
Merovci, Aurora ;
Solis-Herrera, Carolina ;
Daniele, Giuseppe ;
Eldor, Roy ;
Fiorentino, Teresa Vanessa ;
Tripathy, Devjit ;
Xiong, Juan ;
Perez, Zandra ;
Norton, Luke ;
Abdul-Ghani, Muhammad A. ;
DeFronzo, Ralph A. .
JOURNAL OF CLINICAL INVESTIGATION, 2014, 124 (02) :509-514
[4]  
Perkins BA, 2013, 73 AM DIAB ASS SCI S